Summit Therapeutics Inc. 8-K Filing
Ticker: SMMT · Form: 8-K · Filed: Jun 3, 2024 · CIK: 1599298
| Field | Detail |
|---|---|
| Company | Summit Therapeutics Inc. (SMMT) |
| Form Type | 8-K |
| Filed Date | Jun 3, 2024 |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
FAQ
What type of filing is this?
This is a 8-K filing submitted by Summit Therapeutics Inc. (ticker: SMMT) to the SEC on Jun 3, 2024.
What are the key financial figures in this filing?
Key dollar amounts include: $0.01 (nge on Which Registered Common stock, $0.01 par value per share SMMT The Nasdaq).
How long is this filing?
Summit Therapeutics Inc.'s 8-K filing is 2 pages with approximately 729 words. Estimated reading time is 3 minutes.
Where can I view the full 8-K filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Stats: 729 words · 3 min read · ~2 pages · Grade level 11 · Accepted 2024-06-03 06:05:37
Key Financial Figures
- $0.01 — nge on Which Registered Common stock, $0.01 par value per share SMMT The Nasdaq
Filing Documents
- d38200d8k.htm (8-K) — 27KB
- d38200dex991.htm (EX-99.1) — 8KB
- d38200dex992.htm (EX-99.2) — 65KB
- d38200dex993.htm (EX-99.3) — 18KB
- g38200dsp4.jpg (GRAPHIC) — 13KB
- g38200ex99_1p10g1.jpg (GRAPHIC) — 241KB
- g38200ex99_1p11g1.jpg (GRAPHIC) — 241KB
- g38200ex99_1p12g1.jpg (GRAPHIC) — 273KB
- g38200ex99_1p13g1.jpg (GRAPHIC) — 237KB
- g38200ex99_1p14g1.jpg (GRAPHIC) — 240KB
- g38200ex99_1p15g1.jpg (GRAPHIC) — 212KB
- g38200ex99_1p16g1.jpg (GRAPHIC) — 331KB
- g38200ex99_1p17g1.jpg (GRAPHIC) — 284KB
- g38200ex99_1p18g1.jpg (GRAPHIC) — 315KB
- g38200ex99_1p19g1.jpg (GRAPHIC) — 170KB
- g38200ex99_1p1g1.jpg (GRAPHIC) — 435KB
- g38200ex99_1p20g1.jpg (GRAPHIC) — 201KB
- g38200ex99_1p2g1.jpg (GRAPHIC) — 371KB
- g38200ex99_1p3g1.jpg (GRAPHIC) — 310KB
- g38200ex99_1p4g1.jpg (GRAPHIC) — 259KB
- g38200ex99_1p5g1.jpg (GRAPHIC) — 238KB
- g38200ex99_1p6g1.jpg (GRAPHIC) — 250KB
- g38200ex99_1p7g1.jpg (GRAPHIC) — 262KB
- g38200ex99_1p8g1.jpg (GRAPHIC) — 231KB
- g38200ex99_1p9g1.jpg (GRAPHIC) — 227KB
- 0001193125-24-152292.txt ( ) — 7617KB
- smmt-20240531.xsd (EX-101.SCH) — 3KB
- smmt-20240531_lab.xml (EX-101.LAB) — 18KB
- smmt-20240531_pre.xml (EX-101.PRE) — 11KB
- d38200d8k_htm.xml (XML) — 4KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 99.1 ASCO Presentation 99.2 Press Release, dated May 31, 2024 99.3 Press Release, dated June 1, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized. SUMMIT THERAPEUTICS INC. Date: June 3, 2024 By: /s/ Manmeet S. Soni Chief Operating Officer and Chief Financial Officer (Principal Financial Officer)